RJTCONH
MRK icon

Raymond James Trust Company of New Hampshire’s Merck MRK Stock Holding History

Raymond James Trust Company of New Hampshire’s Portfolio MRK Stock Details MRK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-1,994
Closed -$221K – 20
2022
Q4 		$221K Sell
1,994
-412
-17% -$42.1K 1.99% 17
2022
Q3 		$207K Buy
+2,406
New +$215K 1.81% 19

Other funds holding MRK

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Raymond James Trust Company of New Hampshire's MRK Position: Q1 2023 in Review

Raymond James Trust Company of New Hampshire sold out of Merck (MRK) in Q1 2023, closing a stake of 1,994 shares — an estimated $221K sold.

Raymond James Trust Company of New Hampshire first reported a position in MRK in Q3 2022 and held it in 2 quarters. The position peaked at $221K in Q4 2022. 3,180 funds tracked by Wall St. Rank hold MRK as of Q1 2023.

  • Raymond James Trust Company of New Hampshire reported no remaining Merck position as of Q1 2023 after selling out during the quarter.
  • Raymond James Trust Company of New Hampshire sold 1,994 Merck shares in Q1 2023, an estimated $221K.
  • Raymond James Trust Company of New Hampshire first reported a position in Merck in Q3 2022 and held it in 2 quarters.
  • Raymond James Trust Company of New Hampshire's Merck position peaked at $221K in Q4 2022.
  • 3,180 funds tracked by Wall St. Rank held Merck as of Q1 2023.

Based on Raymond James Trust Company of New Hampshire's 13F filing for Q1 2023, filed 3 May 2023.